Kavli–Krebs Prize Lecture: Professor Robert Langer Delivers Inaugural Talk on Advances in Drug Delivery and Tissue Engineering
The University of Oxford’s first Kavli–Sir Hans Krebs Prize Lecture was delivered to a full lecture theatre by Professor Robert S. Langer, a world-leading scientist and entrepreneur renowned for his pioneering work in drug delivery systems and tissue engineering. Professor Langer, who is also a co-founder of Moderna, has made significant contributions across chemical engineering, nanotechnology, and biology.
In his talk, Professor Langer shared stories from the early stages of his career, highlighting the challenges he faced as a chemical engineer entering the field of biology at a time when interdisciplinary research was far from common. He described his journey to MIT and how persistence, creativity and opportunity shaped his path towards groundbreaking discoveries in bioengineering. His lecture showcased how interdisciplinary approaches can lead to transformational advances in medicine.
Following the lecture, guests gathered for a drinks reception at the Kavli Institute for Nanoscience Discovery, where researchers had the chance to meet Professor Langer and continue discussions sparked by the event.
Professor Dame Carol Robinson, Director of Kavli Oxford, said:
“We were delighted that Bob was able to deliver the first Kavli–Krebs Prize Lecture and medal. His talk was truly inspirational and his achievements are outstanding.”
Professor David Paterson, Head of the Department of Physiology, Anatomy and Genetics, added:
“His lecture was an excellent example of interdisciplinarity – bridging the physical sciences and the life sciences.”
Professor Dame Molly Stevens, Co-Deputy of Kavli Oxford said:
"It was such a pleasure to host Bob who was my postdoctoral mentor at MIT. My current group were over the moon at meeting him and listening to his inspirational talk.”
Kavli Oxford extends its thanks to Professor Dame Molly Stevens for organising this successful event.